Kura Oncology Stock Forecast - Accumulation Distribution
| KURA Stock | USD 11.17 0.42 3.91% |
Kura Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Kura Oncology stock prices and determine the direction of Kura Oncology's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Kura Oncology's historical fundamentals, such as revenue growth or operating cash flow patterns.
Kura |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 3.7 M | 766390.0 |
| Check Kura Oncology Volatility | Backtest Kura Oncology | Trend Details |
Kura Oncology Trading Date Momentum
| On November 25 2024 Kura Oncology was traded for 10.96 at the closing time. The top price for the day was 11.35 and the lowest listed price was 10.63 . The trading volume for the day was 4 M. The trading history from November 25, 2024 was a factor to the next trading day price jump. The trading delta at closing time against the next closing price was 1.48% . The trading delta at closing time against the current closing price is 0.83% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Kura Oncology to competition |
Other Forecasting Options for Kura Oncology
For every potential investor in Kura, whether a beginner or expert, Kura Oncology's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Kura Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Kura. Basic forecasting techniques help filter out the noise by identifying Kura Oncology's price trends.View Kura Oncology Related Equities
| Risk & Return | Correlation |
Kura Oncology Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Kura Oncology's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Kura Oncology's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Kura Oncology Market Strength Events
Market strength indicators help investors to evaluate how Kura Oncology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Kura Oncology shares will generate the highest return on investment. By undertsting and applying Kura Oncology stock market strength indicators, traders can identify Kura Oncology entry and exit signals to maximize returns.
Kura Oncology Risk Indicators
The analysis of Kura Oncology's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Kura Oncology's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting kura stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.39 | |||
| Standard Deviation | 5.17 | |||
| Variance | 26.75 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Kura Oncology offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Kura Oncology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Kura Oncology Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Kura Oncology Stock:Check out Historical Fundamental Analysis of Kura Oncology to cross-verify your projections. For information on how to trade Kura Stock refer to our How to Trade Kura Stock guide.You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kura Oncology. If investors know Kura will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kura Oncology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.35) | Return On Assets (0.29) | Return On Equity (0.46) |
The market value of Kura Oncology is measured differently than its book value, which is the value of Kura that is recorded on the company's balance sheet. Investors also form their own opinion of Kura Oncology's value that differs from its market value or its book value, called intrinsic value, which is Kura Oncology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kura Oncology's market value can be influenced by many factors that don't directly affect Kura Oncology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kura Oncology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Kura Oncology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kura Oncology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.